Abbott To Try For Summary Judgment In TriCor Suit

Law360, New York (August 5, 2009, 5:43 PM EDT) -- Defendant drug companies Abbott Laboratories and Fournier Industrie et Sante have said they will move for summary judgment in a suit lodged by more than a dozen states alleging the companies conspired to block the release of a generic version of cholesterol drug TriCor with meritless patent infringement suits.

The states' antitrust claims against Abbott and Fournier can be disposed of by summary judgment on several grounds, but the states' alleged discovery delays mean the companies will need more time before trial, they said in a...
To view the full article, register now.